Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olman, M.A.
Right arrow Articles by White, K.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olman, M.A.
Right arrow Articles by White, K.E.
(Chest. 1999;116:118S-119S.)
© 1999 American College of Chest Physicians

Fibrin Fragment Response Elements in the Plasminogen Activator Inhibitor Gene*

M.A. Olman, MD; J.S. Hagood, MD; W.L. Simmons and K.E. White

* From the Divisions of Pulmonary and Critical Care Medicine and Pediatric Pulmonology, University of Alabama at Birmingham, Birmingham, AL.

Correspondence to: M.A. Olman, MD, Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, 1900 University Blvd, THT 215, Birmingham, AL 35294-0006; e-mail: olman{at}pulm.dom.uab.edu

The fibrinolytic protease inhibitor plasminogen activator inhibitor type I (PAI-1) dramatically affects the outcome of lung inflammation and fibrosis in mice injured with either bleomycin or hyperoxia. Furthermore, during human and/or experimental lung injury, fibrin deposition colocalizes with high PAI-1, expressing alveolar mesenchymal cells in the remodeling alveolar matrix. As we have recently shown that PAI-1 is transcriptionally upregulated in lung fibroblasts by the major plasmin proteolytic fragment of fibrin (D-dimer), we undertook this study to determine the cis-acting elements and trans-acting factors that are responsible for fibrin D-dimer's action on PAI-1 transcription.

To study transcriptional activation, lung fibroblasts were transfected with a PAI-1 gene-lucifease reporter construct and stimulated with highly purified D-dimer. To determine the DNA binding proteins, the cells were stimulated with D-dimer and nuclear extracts were harvested for electrophoretic mobility shift assay (EMSA) or Northern blot analysis.

Basal PAI-1 transcriptional activity fell to 25% upon deletion of the -161 to -928 region of the PAI-1 gene and fell further to < 1% of the larger fragment upon deletion of the -161 to -48 region. In transiently transfected fibroblasts, D-dimer exposure (1 µM for 48 h) stimulated PAI-1 transcriptional activation fivefold in a manner that was entirely dependent on the presence of the 5' flanking region from -48 to -161 base pairs. By EMSA, D-dimer stimulation resulted in a specific, time (peak 45 min) and dose-dependent induction (peak sixfold at 100 nM to 1 µM) of c-fos/junD binding, as identified using specific antibodies, to the -66 to -45 base pairs DNA element of the PAI-1 gene. Mutation of the putative AP-1 binding site (-59 to -52) to a non-AP-1 binding mutant (as validated by EMSA) reduced basal transcriptional activity threefold and resulted in a complete loss of overexpressed c-fos inducibility of PAI-1 transcription in cotransfection assays.

These results indicate that the c-fos/junD binds to and transcriptionally activates the PAI-1 gene (by the -59 to -52 sequence) in response to fibrin-derived D-dimer in a dose- and time-dependent manner. As hyaline membranes and pulmonary fibrotic lesions contain fibrin and high PAI-1-expressing fibroblasts, these data provide further support for the importance of fibrin proteolytic fragments in the feedback regulation of PAI-1 expression and in the biology of matrix remodeling after acute lung injury.

Footnotes

This research was supported by a VA MERIT grant and by the National Heart, Lung, and Blood Institute.





This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olman, M.A.
Right arrow Articles by White, K.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olman, M.A.
Right arrow Articles by White, K.E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS